Is HGH or ORCC a better dividend investment in 2026?

HGH currently yields 61.22% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: HGH offers higher current income.

What is the dividend yield difference between HGH and ORCC?

HGH has a forward dividend yield of 61.22% ($15.31/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 51.43 percentage points.

Home › Compare › HGH vs ORCC

HGH vs ORCC: Dividend Comparison 2026

HGH yields 61.22% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HGH wins by $10.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

HGH

● Live price

61.22%

Share price

$25.01

Annual div

$15.31

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$32.2K

Annual income

$9.77

Full HGH calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — HGH vs ORCC

📍 HGH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HGH	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HGH + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HGH pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HGH

Annual income on $10K today (after 15% tax)

$5,203.34/yr

After 10yr DRIP, annual income (after tax)

$8.30/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, HGH beats the other by $7.42/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HGH + ORCC for your $10,000?

HGH: 50%ORCC: 50%

100% ORCC50/50100% HGH

Portfolio after 10yr

$26.8K

Annual income

$5.41/yr

Blended yield

0.02%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

HGH

No analyst data

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HGH buys

ORCC buys

No recent congressional trades found for HGH or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHGHORCC

Forward yield	61.22% ✓	9.79%
Annual dividend / share	$15.31 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	-50%
Portfolio after 10y	$32.2K ✓	$21.4K
Annual income after 10y	$9.77 ✓	$1.04
Total dividends collected	$7.3K ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: HGH vs ORCC ($10,000, DRIP)

Year	HGH Portfolio	HGH Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$13,761	$3,060.79	$11,190	$489.61	+$2.6K → HGH
2	$16,692	$1,968.17	$12,229	$256.01	+$4.5K → HGH
3	$18,976	$1,115.63	$13,216	$130.74	+$5.8K → HGH
4	$20,897	$592.66	$14,207	$66.02	+$6.7K → HGH
5	$22,665	$304.98	$15,234	$33.17	+$7.4K → HGH
6	$24,406	$154.57	$16,317	$16.62	+$8.1K → HGH
7	$26,192	$77.78	$17,468	$8.32	+$8.7K → HGH
8	$28,065	$39.00	$18,695	$4.16	+$9.4K → HGH
9	$30,049	$19.53	$20,006	$2.08	+$10.0K → HGH
10	$32,162	$9.77	$21,407	$1.04	+$10.8K → HGH

HGH vs ORCC: Complete Analysis 2026

HGH — Stock

HGH is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in HGH shares.

Full HGH Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this HGH vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HGH vs SCHD HGH vs JEPI HGH vs O HGH vs KO HGH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.